Indications and uses
For the temporary relief of symptoms caused by fleas and mange, including itching, swelling, soreness, inflammation, and sensitivity. Indications based on the Homeopathic Materia Medica for self-limiting conditions.
For the temporary relief of symptoms caused by fleas and mange, including itching, swelling, soreness, inflammation, and sensitivity. Indications based on the Homeopathic Materia Medica for self-limiting conditions.
For pet use: wet fur with warm water and apply Defendex to fur and coat. Work into a lather. Massage Defendex into fur for at least ten minutes. Rinse thoroughly and repeat as needed, up to 3 times per week. Use lice/nit removing comb as needed.
Keep product away from direct sunlight, prolonged temperatures above 80 F, and strong electromagnetic fields. Store in a dark place and keep container tightly closed.
Agaricus musc, Bovista,
Muriaticum ac, Pix liquida,
Staphysag, Sulphur HPUS
Anacardium or,
Apis mel HPUS
Causticum,
Graphites 8X, HPUS
Oleander HPUS
Quassia HPUS
Rhus tox HPUS
Each active ingredient contains equal volumes of 6X potencies unless otherwise indicated. The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
Agaricus musc, Bovista,
Muriaticum ac, Pix liquida,
Staphysag, Sulphur HPUS.....................Itching
Anacardium or,
Apis mel HPUS.....................................Swelling
Causticum,
Graphites 8X, HPUS.............................Soreness
Oleander HPUS....................................Sensitivity
Quassia HPUS.....................................Pain
Rhus tox HPUS....................................Inflammation
For the temporary relief of symptoms caused by fleas and mange, including itching, swelling, soreness, inflammation, and sensitivity.
Indications based on the Homeopathic Materia Medica for self-limiting conditions.
Avoid all contact with ears and eyes to prevent irritation. If contact with eyes occurs, flush immediately with water.
If irritation develops, or if product is accidentally ingested, call your veterinarian and/or poison control center immediately.
Keep out of the reach of children and pets.
For pet use: wet fur with warm water and apply Defendex to fur and coat. Work into a lather.
Massage Defendex into fur for at least ten minutes. Rinse thoroughly and repeat as needed, up to 3 times per week. Use lice/nit removing comb as needed.
Keep product away from direct sunlight, prolonged temperatures above 80 F, and strong electromagnetic fields.
Store in a dark place and keep container tightly closed.
aloe barbadensis leaf, sodium lauroyl sarcosinate, purified water, cocamidopropyl betaine, melia azadirachta (neem) seed oil (5%), illicium verum (anise) oil (2%), PEG-150 distearate, wheatgermamidopropyl dimethylamine hydrolyzed wheat protein, glycerin, diazolidinyl urea, sodium chloride, formic acid, potassium sorbate, citric acid.
If you have any questions, please call 1-866-977-0888 Mon.-Fri., 9am-5pm ET View our complete line of pet care products at
www.vetionx.com
Distributed by
VETIONX
4460 44th St. SE Ste. C-600
Grand Rapids, MI 49512
NDC 50364-012-04
DEFENDEX
Flea and Mange Symptom Shampoo
HOMEOPATHIC SHAMPOO
For All Pets and Animals (OTC) relief
4 fl oz (118 mL)
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50364-012 | DEFENDEX (AGARICUS MUSCARIUS, BOVISTA, MURIATICUM ACIDUM, PIX LIQUIDA, STAPHYSAGRIA, SULPHUR, ANACARDIUM ORIENTALE, APIS MELLIFICA, CAUSTICUM, GRAPHITES, OLEANDER, QUASSIA, RHUS TOXICODENDRON) SHAMPOO [IONX HEALTH D/B/A VETIONX] | 3 | Unmatched | 20160928_909b9a95-480d-4f3e-abbe-194b9e7f8baf.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AMANITA MUSCARIA VAR. MUSCARIA FRUITING BODY | ACTIVE INGREDIENT | DIF093I037 | 1 | |
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| CAUSTICUM | ACTIVE INGREDIENT | DD5FO1WKFU | 1 | |
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE INGREDIENT | 00543AP1JV | 1 | |
| GRAPHITE | ACTIVE INGREDIENT | 4QQN74LH4O | 1 | |
| HYDROCHLORIC ACID | ACTIVE INGREDIENT | QTT17582CB | 1 | |
| LYCOPERDON UTRIFORME FRUITING BODY | ACTIVE INGREDIENT | K2A74U428F | 1 | |
| NERIUM OLEANDER LEAF | ACTIVE INGREDIENT | 7KV510R6H6 | 1 | |
| PINE TAR | ACTIVE INGREDIENT | YFH4WC535J | 1 | |
| QUASSIA AMARA WHOLE | ACTIVE INGREDIENT | O2G7GY29MO | 1 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE INGREDIENT | Y0F0BU8RDU | 1 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| AMANITA MUSCARIA VAR. MUSCARIA FRUITING BODY | ACTIVE MOIETY | DIF093I037 | 1 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| CAUSTICUM | ACTIVE MOIETY | DD5FO1WKFU | 1 | |
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE MOIETY | 00543AP1JV | 1 | |
| GRAPHITE | ACTIVE MOIETY | 4QQN74LH4O | 1 | |
| HYDROCHLORIC ACID | ACTIVE MOIETY | QTT17582CB | 1 | |
| LYCOPERDON UTRIFORME FRUITING BODY | ACTIVE MOIETY | K2A74U428F | 1 | |
| NERIUM OLEANDER LEAF | ACTIVE MOIETY | 7KV510R6H6 | 1 | |
| PINE TAR | ACTIVE MOIETY | YFH4WC535J | 1 | |
| QUASSIA AMARA WHOLE | ACTIVE MOIETY | O2G7GY29MO | 1 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE MOIETY | Y0F0BU8RDU | 1 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| AZADIRACHTA INDICA SEED OIL | INACTIVE INGREDIENT | 4DKJ9B3K2T | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| COCAMIDOPROPYL BETAINE | INACTIVE INGREDIENT | 5OCF3O11KX | 1 | |
| DIAZOLIDINYL UREA | INACTIVE INGREDIENT | H5RIZ3MPW4 | 1 | |
| FORMIC ACID | INACTIVE INGREDIENT | 0YIW783RG1 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| PEG-150 DISTEARATE | INACTIVE INGREDIENT | 6F36Q0I0AC | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM LAUROYL SARCOSINATE | INACTIVE INGREDIENT | 632GS99618 | 1 | |
| STAR ANISE OIL | INACTIVE INGREDIENT | 6RXP35EIRE | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50364-012 | 50364-012-04, 50364-012-12 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAMUSCULAR | 1486 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 30 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ELIXIR / ORAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 69 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1800 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 69 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.